MORNING RECAP 🔸 EVgo Inc ( $EVGO) launches secondary offering of 23 million Class A shares. 🔸 Mama's Creations ( $MAMA) Q3: EPS $0.01 (est. $0.04), adj. EBITDA $1.7M (est. $3.229M), revenue $31.5M (est. $30.05M). 🔸 McCormick ( $MKC) reportedly negotiating to acquire Sauer brands for $1 billion. 🔸 RCI Hospitality ( $RICK) Q4: adj. EPS $1.63 (est. $0.37), adj. EBITDA $17.9M (est. $13.92M), revenue $73.2M (est. $72.98M); forecasts FY29 revenue at $400M, FCF at $75M with 7.5M shares. 🔸 Tesla ( $TSLA) upgraded to Overweight by Mizuho, target price raised to $515. 🔸 Online sports betting: New Jersey's November handle exceeds $1.2B, with $119M in revenue, up 24.1% from last year. 🔸 Compass Minerals ( $CMP) Q4: adj. EPS loss (-$0.77) vs. est. (-$0.44), revenue $208.8M vs. est. $213.5M; adj. EBITDA $15.6M. 🔸 Expects 2025 salt sales volumes up 9% and 2024 Plant Nutrition volumes up 25% to 273K tons. 🔸 Kosmos Energy ( $KOS) abandons acquisition talks with Tullow Oil. 🔸 Joby Aviation ( $JOBY) completes major FAA certification tests for aerostructures. 🔸 Nucor Corp. ( $NUE) lowers Q4 EPS guidance to $0.55-$0.65, below consensus of $0.87. 🔸 Owens Corning ( $OC) upgraded to Overweight by Wells Fargo. 🔸 Biden administration offers PG&E ( $PCG) a $15B loan for climate and grid improvement projects. 🔸 Affirm Holdings ( $AFRM) issues $750M in Convertible Senior Notes due 2029, plans to repurchase up to $300M in Class A stock. 🔸 Marqeta ( $MQ) downgraded to Equal Weight by Barclays. 🔸 Jazz Pharmaceuticals ( $JAZZ) CEO Bruce Cozadd to retire by end of 2025. 🔸 Rockwell Medical ( $RMTI) secures multi-year deal with top dialysis provider, anticipating $10M+ in 2025 sales, with annual price increases and a term up to five years. 🔸 eBay Inc ( $EBAY) board approved an additional $3B for stock repurchases on Dec 12. 🔸 Mitek Systems ( $MITK) Q4: adj. EPS $0.33 (est. $0.17), adj. EBITDA $15.4M (est. $8.314M), revenue $43.222M (est. $41.31M); FY25 guidance: revenue $170-180M (est. $179.52M), adj. EBITDA margin 24-28%.

MOVING UP $GAP surged 5% after an upgrade to Overweight from Neutral by JP Morgan, with a new price target of $30. They revised their FY25 EPS to $2.30 and FY26 EPS to $2.53, expecting revenue growth and margin expansion. $INTC rose 2% on CEO Pat Gelsinger's retirement announcement. David Zinsner and Michelle Johnston Holthaus are appointed interim Co-CEOs, with Frank Yeary as Interim Executive Chair while a permanent successor is sought. $NBIS soared 16% after securing $700M through a private placement involving NVDA, planning to issue 33.33M Class A shares at $21/share. $NVCR jumped 30% following successful trial results where its cancer therapy, combined with chemotherapy, extended pancreatic cancer patient survival from 14.16 to 16.20 months on average. $PTCT climbed 14% after licensing its experimental Huntington's Disease drug, PTC518, to a Novartis unit for up to $2.9B, with $1B upfront. $SMCI increased 14% after confirming no need to restate financials, with no evidence of shipping incomplete products to boost quarterly revenue. $TNDM went up 6% after an upgrade to Overweight from Equal Weight by Morgan Stanley, with a $45 price target, citing undervalued stock and potential in type-2 diabetes market expansion. $TSLA gained 2% with Stifel maintaining its Buy rating, raising the target to $411, praising Tesla's broader market vision beyond just being an automaker. Additionally, Roth MKM upgraded TSLA to Buy, setting a $380 target, highlighting potential catalysts for value increase. MOVING DOWN $CORZ drops 5% on news of a $500M convertible senior notes offer for 2031. $NU falls 5%, hit by Citigroup's downgrade to Sell, citing profit-taking despite strong growth in Brazil. $PCG slides 5% after announcing $2.4B in stock offerings. $STLA tumbles 8% following CEO Carlos Tavares' sudden resignation after nearly four years. $UPST plunges 11%, downgraded to Underweight at JP Morgan, with caution advised on fintech at current valuations.